Abstract: A loop avoidance method, device and system. The system includes a first network device and a second network device in an internal network, a first Ethernet port and a second Ethernet port of the two network devices are of a first type, and loop avoidance priorities of the Ethernet ports are different from each other; root media access control (MAC) addresses of the two network devices are the same, and are different from respective network bridge MAC addresses; the second network device receives a loop detection frame from the first Ethernet port through the second Ethernet port, where a source address of the loop detection frame is the root MAC address, and blocks the second Ethernet port according to the loop avoidance priority. A network device blocks, according to a loop avoidance priority, an Ethernet port connected to an external network to avoid changing a topology of an internal network.

Abstract: The present invention relates to the field of medical biology, and discloses a single domain antibody and derivative proteins thereof against programmed death ligand (PDL1). In particular, the present invention discloses a programmed death ligand 1 (PDL1) binding molecular and the use thereof, especially the use for treating and/or preventing or diagnosing PDL1 relevant diseases such as tumor.

Abstract: An inflatable lighting device having a rechargeable, solar powered, and inflatable light. The inflatable lighting device includes an inflatable framework that has inflatable support volumes and a non-inflatable portion, a light assembly in a water proof housing, inlet/outlet architecture to inflate and/or deflate the inflatable support volumes, and an interchangeable decorative sleeve to enclose the inflatable framework.

Abstract: The present invention relates to the field of medical biology, and discloses a single domain antibody and derivative proteins thereof against programmed death ligand (PDL1). In particular, the present invention discloses a programmed death ligand 1 (PDL1) binding molecular and the use thereof, especially the use for treating and/or preventing or diagnosing PDL1 relevant diseases such as tumor.

Abstract: Disclosed are a fully human monoclonal antibody specifically binding to a CD137 or an antigen binding portion thereof. On one hand, provided are a CDR/variable region sequence of the antibody and an encoding nucleic acid sequence thereof; on the other hand, provided is a method for treating diseases using the antibody or the antigen binding portion thereof. a fully human monoclonal antibody specifically binding to a CD137 or an antigen binding portion thereof. On one hand, provided are a CDR/variable region sequence of the antibody and an encoding nucleic acid sequence thereof; on the other hand, provided is a method for treating diseases using the antibody or the antigen binding portion thereof.

Abstract: An artificial neural network for analyzing input data, the input data being a 3D tensor having D channels, such as D frames of a video snippet, to recognize an action therein, including: D spatial transformer modules, each generating first and second spatial transformations and corresponding first and second attention windows using only one of the D channels, and transforming first and second regions of each of the D channels corresponding to the first and second attention windows to generate first and second patch sequences; first and second CNNs, respectively processing a concatenation of the D first patch sequences and a concatenation of the D second patch sequences; and a classification network receiving a concatenation of the outputs of the first and second CNNs and the D sets of transformation parameters of the first transformation outputted by the D spatial transformer modules, to generate a predicted action class.

Abstract: A data scheduling method and customer premises equipment are provided. The customer premises equipment stores, in a first queue, received service data that is sent from a first network to a second network. Test data is generated that is to be sent from the first network to the second network. The test data is stored in a second queue. The customer premises equipment preferentially schedules the service data in the first queue to be in a third queue and in response to determining that a rate at which the service data is received is lower than a preset limit rate, schedules the test data in the second queue to be in the third queue to reach the limit rate. The service data and/or the test data in the third queue is sent to the second network at the limit rate.

Abstract: Disclosed herein is a gonadotropin fusion protein or a thyroid stimulating hormone fusion protein, a method for preparing the same and use thereof. ?-subunit of the gonadotropin or thyroid stimulating hormone is fused to an Fc fragment directly or indirectly through a linker, and ?-subunit binds to the ?-subunit via an affinity between the ?-subunit and the ?-subunit. The fusion protein has a prolonged half-life and less fluctuating activity.

Abstract: The present invention provides bis-polymer lipid-peptide conjugates containing a hydrophobic block and headgroup containing a helical peptide and two polymer blocks. The conjugates can self-assemble to form helix bundle subunits, which in turn assemble to provide micellar nanocarriers for drug cargos and other agents. Particles containing the conjugates and methods for forming the particles are also disclosed.

Abstract: A hammock includes an arcuate support frame configured for periodic rotational locomotion. A resilient support surface is configured for supporting a mass of at least one user thereon during a periodic rotational locomotion. The support surface may be suspended by suspension members between opposing ends of the support frame. The suspension member may be configured for a range of center of mass adjustment points for modifying a collective center of mass location for the rotational locomotion.

Abstract: A hammock includes a resilient support surface for supporting a mass of at least one object thereon, and a separation element being disposed in the support surface defining a plurality of separable support sections.

Abstract: An outdoor amusement rocking device having a frame and a support member that together form a curvature saddle-shaped play structure. The amusement device includes a hyperbole paraboloid frame structure defining an interior area and a resilient support sheet material disposed in the interior area of the frame and attached to the frame.

Abstract: The present disclosure provides proteinaceous heterodimers, pharmaceutical compositions, medicaments and/or kits comprising the proteinaceous heterodimers, methods for producing the proteinaceous heterodimers, and uses thereof.

Abstract: An outdoor amusement rocking device having a frame and a support member that together form a curvature saddle-shaped play structure. The amusement device includes a hyperbole paraboloid frame structure defining an interior area and a resilient support sheet material disposed in the interior area of the frame and attached to the frame.

Abstract: A recreational swing having a seating member to support one or more users thereon, and a suspension system that includes one or more bungee cords that permit the base seating portion to be suspended from a suspension point so as to dually function as a swing.

Abstract: An outdoor amusement rocking device having a frame and a support member that together form a curvature saddle-shaped play structure. The amusement device includes a hyperbole paraboloid frame structure defining an interior area and a resilient support sheet material disposed in the interior area of the frame and attached to the frame.